Additional Details

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Indiana University Health Enterprise Clinical Research Operation
Indianapolis, IN 46202